$0.8710
0.001000.11%
At close: -
$0.8500
-0.02-2.41%
After Hours: 4:46 PM EDT
Comments
Loading...
CytoSorbents Stock Guidance | NASDAQ:CTSO | Benzinga
CytoSorbents issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/31/2023 | CTSO | CytoSorbents | FY | 2022 | — | — | — | $34.70M | $34.70M | $33.57M | Get Alert |
| 01/31/2023 | CTSO | CytoSorbents | Q4 | 2022 | — | — | — | $9.40M | $9.40M | $8.90M | Get Alert |
| 01/18/2022 | CTSO | CytoSorbents | Q4 | 2021 | — | — | — | $10.80M | $10.80M | $9.58M | Get Alert |
| 01/18/2022 | CTSO | CytoSorbents | FY | 2021 | — | — | — | $43.20M | $43.20M | $41.95M | Get Alert |
| 10/12/2021 | CTSO | CytoSorbents | Q3 | 2021 | — | — | — | $9.70M | $9.70M | $11.96M | Get Alert |
| 01/12/2021 | CTSO | CytoSorbents | Q4 | 2020 | — | — | — | $11.80M | $11.80M | $10.81M | Get Alert |
FAQ
What is the most recent guidance for CytoSorbents (CTSO)?
There have been no specific sales or earnings guidance reported for CytoSorbents in recent months.
Browse guidance and forecast on all stocks.
